Coronary angioplasty aka PCI is a common procedure with excellent success rates. The in-hospital mortality following PCI is 1-2% and in the setting of acute coronary syndrome is 3%. Additionally,1-2% of patients die after discharge within 30 days. Two recent retrospective database analyses from the states of New York and Michigan Blue shield studied mortality after PCI1,2. The New York database included 135,000 patients studying in-hospital and 30-day mortality while the Michigan database had 92,000 patients analysing in-hospital mortality. I present these papers with the learning points so that we can improve patient outcomes. The findings Both databases showed a 1.5% - 30-day mortality after PCI. 30% of these deaths are preventable. Most in-hospital deaths were non preventable (70%). They were attributed to pre-existing cardiac conditions such as cardiogenic shock, left ventricular failure, co-morbidities etc. Most of them are emergency and high-risk patients. 30% of in-hospital
Nowadays, heart ailments are on a steep rise. An erratic work schedule and the stress associated with it make people prey to cardiac problems. One such ailment that is often heard of is Hypertrophic Cardiomyopathy. In simple terms, this is a specific heart ailment that causes the heart muscles to enlarge. Let us tell you more about this problem, its symptoms, and treatment. What is Hypertrophic Cardiomyopathy Hypertrophic Cardiomyopathy can affect your heart in the following ways: Thickening of the heart muscles Changes in the Mitral valve Stiffness in the left ventricle Since this problem thickens your heart muscles, it blocks the flow of the flood. When the blood flow is affected, it will impact the heart's processes. Symptoms of Hypertrophic Cardiomyopathy Let us now first tell you about the symptoms of Hypertrophic Cardiomyopathy. Chest pain- This is the most common symptom of Cardiomyopathy as well as Myocarditis . Usually, this happens after strenuous exercise. So